Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-05-24
DOI
10.3389/fphar.2021.667874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
- (2021) Yanxing Chen et al. Alzheimers Research & Therapy
- NRF2 as a Therapeutic Target in Neurodegenerative Diseases
- (2020) Mikah S. Brandes et al. ASN Neuro
- Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
- (2020) Ana I. Duarte et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
- (2020) Salinee Jantrapirom et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin Ameliorates Aβ Pathology by Insulin-Degrading Enzyme in a Transgenic Mouse Model of Alzheimer’s Disease
- (2020) Xin-Yi Lu et al. Oxidative Medicine and Cellular Longevity
- Diverse roles of mtDNA in schizophrenia: Implications in its pathophysiology and as biomarker for cognitive impairment
- (2020) Samuel Suárez-Méndez et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin
- (2020) Gaber El-Saber Batiha et al. Foods
- Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane
- (2020) Robin H. Isaacson et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats
- (2020) Chao Luo et al. PSYCHOPHARMACOLOGY
- Metformin Ameliorates Synaptic Defects in a Mouse Model of AD by Inhibiting Cdk5 Activity
- (2020) YaLi Wang et al. Frontiers in Cellular Neuroscience
- Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
- (2020) Suzanne Craft et al. JAMA Neurology
- The physiology of regulated BDNF release
- (2020) Tanja Brigadski et al. CELL AND TISSUE RESEARCH
- Mechanisms underlying the comorbidity of schizophrenia and type 2 diabetes mellitus
- (2020) Yutaka Mizuki et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia
- (2020) Qi Tao et al. Frontiers in Psychiatry
- Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders: A systematic review
- (2019) Caroline Vintergaard Ott et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer’s Disease
- (2019) Ari Robinson et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia
- (2019) S. Andrea Wijtenburg et al. SCHIZOPHRENIA RESEARCH
- Metformin protects PC12 cells and hippocampal neurons from H2 O 2 -induced oxidative damage through activation of AMPK pathway
- (2019) Xia Zhao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antidiabetic effect of quercetin: A systematic review and meta-analysis of animal studies
- (2019) Mohammed Bule et al. FOOD AND CHEMICAL TOXICOLOGY
- Neuroinflammation and cognition across psychiatric conditions
- (2019) Célia Fourrier et al. CNS SPECTRUMS
- Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β
- (2019) Mei Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Efficacy of Intranasal Insulin in Improving Cognition in Mild Cognitive Impairment and Alzheimer Disease
- (2019) Jian Lu et al. AMERICAN JOURNAL OF THERAPEUTICS
- Mitochondrial Dysfunction Leads to Cortical Under-Connectivity and Cognitive Impairment
- (2019) Alejandra Fernandez et al. NEURON
- Brain insulin action in schizophrenia: something borrowed and something new
- (2019) Sri Mahavir Agarwal et al. NEUROPHARMACOLOGY
- Brain insulin action: implications for the treatment of schizophrenia
- (2019) Sri Mahavir Agarwal et al. NEUROPHARMACOLOGY
- Protective role of metformin against methamphetamine induced anxiety, depression, cognition impairment and neurodegeneration in rat: The role of CREB/BDNF and Akt/GSK3 signaling pathways
- (2019) Saghar Keshavarzi et al. NEUROTOXICOLOGY
- Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer’s Disease
- (2019) Susan A. Farr et al. JOURNAL OF ALZHEIMERS DISEASE
- Exercise Alleviates Cognitive Functions by Enhancing Hippocampal Insulin Signaling and Neuroplasticity in High-Fat Diet-Induced Obesity
- (2019) Hye-Sang Park et al. Nutrients
- Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5×FAD mouse model of Alzheimer’s disease
- (2019) Jingjing An et al. BEHAVIOURAL BRAIN RESEARCH
- Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats
- (2019) Xu Wang et al. BRAIN RESEARCH
- Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia
- (2019) Xiangyang Zhang et al. MOLECULAR PSYCHIATRY
- Insulin-signaling abnormalities in drug-naïve first-episode schizophrenia: Transduction protein analyses in extracellular vesicles of putative neuronal origin
- (2019) Dimitrios Kapogiannis et al. EUROPEAN PSYCHIATRY
- PPARγ and Cognitive Performance
- (2019) Michele d’Angelo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer’s Disease
- (2019) Manuela Bomba et al. JOURNAL OF ALZHEIMERS DISEASE
- DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
- (2019) Shuyi Chen et al. NEUROPHARMACOLOGY
- Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease
- (2019) Byron Creese et al. Translational Psychiatry
- Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation
- (2019) Wenting Fang et al. JOURNAL OF AFFECTIVE DISORDERS
- Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: A mechanistic review
- (2019) Habib Yaribeygi et al. LIFE SCIENCES
- Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
- (2019) Yam Nath Paudel et al. PHARMACOLOGICAL RESEARCH
- Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt/beta catenin pathway via targeting alpha- and beta-secretases
- (2019) Naglaa Assaf et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Oral pioglitazone ameliorates fructose-induced peripheral insulin resistance and hippocampal gliosis but not restores inhibited hippocampal adult neurogenesis
- (2018) Wen-Chung Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
- (2018) Zhenri Ou et al. BRAIN BEHAVIOR AND IMMUNITY
- Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin
- (2018) O.M. Abdelwahed et al. BRAIN RESEARCH BULLETIN
- Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis
- (2018) Bing Cao et al. DIABETES OBESITY & METABOLISM
- The role of Nrf2 signaling in counteracting neurodegenerative diseases
- (2018) Albena T. Dinkova-Kostova et al. FEBS Journal
- Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging
- (2018) Alexandra M.V. Wennberg et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review
- (2018) Konstantinos Ioannis Avgerinos et al. JOURNAL OF NEUROLOGY
- The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
- (2018) Andre F Batista et al. JOURNAL OF PATHOLOGY
- Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats
- (2018) Ilijana Babic et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Buttermilk and Krill Oil Phospholipids Improve Hippocampal Insulin Resistance and Synaptic Signaling in Aged Rats
- (2018) Joao Tomé-Carneiro et al. MOLECULAR NEUROBIOLOGY
- Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice
- (2018) Manuela Bomba et al. NEUROBIOLOGY OF AGING
- Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?
- (2018) Rodrigo B. Mansur et al. NEUROPHARMACOLOGY
- Protective Effects of Sulforaphane on Cognitive Impairments and AD-like Lesions in Diabetic Mice are Associated with the Upregulation of Nrf2 Transcription Activity
- (2018) Die Pu et al. NEUROSCIENCE
- Sulforaphane ameliorates glucose intolerance in obese mice via upregulation of insulin signaling pathway
- (2018) Yan Xu et al. Food & Function
- The influence of quercetin on recognition memory and brain oxidative damage in a ketamine model of schizophrenia
- (2018) Derya Guliz Mert et al. Psychiatry and Clinical Psychopharmacology
- Recent updates on GLP-1 agonists: Current advancements & challenges
- (2018) Dilip Sharma et al. BIOMEDICINE & PHARMACOTHERAPY
- Glucagon-like peptide-1 receptor-agonists for antipsychotic-associated cardio-metabolic risk factors: a systematic review and individual participant data meta-analysis
- (2018) Dan Siskind et al. DIABETES OBESITY & METABOLISM
- The Neuroprotection of Liraglutide on Alzheimer-Like Learning and Memory Impairment by Modulating the Hyperphosphorylation of Tau and Neurofilament Proteins and Insulin Signaling Pathways in Mice
- (2018) Hui Xiong et al. JOURNAL OF ALZHEIMERS DISEASE
- Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease
- (2018) Amy Claxton et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
- (2018) Yufeng Lin et al. Frontiers in Aging Neuroscience
- Neural correlates of liraglutide effects in persons at risk for Alzheimer’s disease
- (2018) Kathleen T. Watson et al. BEHAVIOURAL BRAIN RESEARCH
- Insulin resistance: Review of the underlying molecular mechanisms
- (2018) Habib Yaribeygi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Evidence for genetic contribution to the increased risk of type 2 diabetes in schizophrenia
- (2018) Sophie Hackinger et al. Translational Psychiatry
- Evidence of metabolic memory-induced neurodegeneration and the therapeutic effects of glucagon-like peptide-1 receptor agonists via Forkhead box class O
- (2018) Song Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease
- (2017) Wei-Chun J. Hsu et al. EXPERIMENTAL NEUROLOGY
- EGCG ameliorates high-fat– and high-fructose–induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS
- (2017) Yashi Mi et al. FASEB JOURNAL
- Quercetin ameliorates chronic unpredicted stress-mediated memory dysfunction in male Swiss albino mice by attenuating insulin resistance and elevating hippocampal GLUT4 levels independent of insulin receptor expression
- (2017) Vineet Mehta et al. HORMONES AND BEHAVIOR
- The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
- (2017) Choon Bae et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels—An Ex Vivo Study
- (2017) Agnieszka Śmieszek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder
- (2017) Danielle S. Cha et al. JOURNAL OF AFFECTIVE DISORDERS
- Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study
- (2017) Rodrigo B. Mansur et al. JOURNAL OF AFFECTIVE DISORDERS
- Behavioral changes in male mice fed a high-fat diet are associated with IL-1β expression in specific brain regions
- (2017) Camila P. Almeida-Suhett et al. PHYSIOLOGY & BEHAVIOR
- Insulin Resistance Disrupts the Interaction Between AKT and the NMDA Receptor and the Inactivation of the CaMKIV/CREB Pathway in Minimal Hepatic Encephalopathy
- (2017) Saidan Ding et al. TOXICOLOGICAL SCIENCES
- SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
- (2017) Piangkwan Sa-nguanmoo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Brain insulin resistance impairs hippocampal synaptic plasticity and memory by increasing GluA1 palmitoylation through FoxO3a
- (2017) Matteo Spinelli et al. Nature Communications
- Impaired Glucose Homeostasis in First-Episode Schizophrenia
- (2017) Toby Pillinger et al. JAMA Psychiatry
- Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder
- (2017) Julie R. Larsen et al. JAMA Psychiatry
- Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults
- (2017) Mark A. Reger et al. JOURNAL OF ALZHEIMERS DISEASE
- Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger
- (2017) Stephanie Kullmann et al. Scientific Reports
- Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice
- (2016) Yan-Fang Mao et al. AGING CELL
- Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function
- (2016) Lay Khoon Too et al. BEHAVIOURAL BRAIN RESEARCH
- Quercetin ameliorates ischemia/reperfusion-induced cognitive deficits by inhibiting ASK1/JNK3/caspase-3 by enhancing the Akt signaling pathway
- (2016) Bing Pei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis
- (2016) Varuni Asanka de Silva et al. BMC Psychiatry
- Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats
- (2016) Enas S. Gad et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Diabetes and Schizophrenia
- (2016) Jaana Suvisaari et al. Current Diabetes Reports
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
- (2016) José A. Luchsinger et al. JOURNAL OF ALZHEIMERS DISEASE
- Activation of PPAR Ameliorates Spatial Cognitive Deficits through Restoring Expression of AMPA Receptors in Seipin Knock-Out Mice
- (2016) L. Zhou et al. JOURNAL OF NEUROSCIENCE
- Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease
- (2016) Jayasankar Kosaraju et al. MOLECULAR NEUROBIOLOGY
- Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
- (2016) Stephanie Kullmann et al. PHYSIOLOGICAL REVIEWS
- The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis
- (2016) E. Bora et al. PSYCHOLOGICAL MEDICINE
- Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
- (2016) Harm J. van de Haar et al. RADIOLOGY
- Quercetin attenuates tau hyperphosphorylation and improves cognitive disorder via suppression of ER stress in a manner dependent on AMPK pathway
- (2016) Junjun Chen et al. Journal of Functional Foods
- Intranasal insulin treatment improves memory and learning in a rat amyloid-beta model of Alzheimer’s disease
- (2016) S Farzampour et al. Physiology International
- Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice
- (2015) Paula L. McClean et al. BEHAVIOURAL BRAIN RESEARCH
- High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents
- (2015) Dmitry Petrov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Hippocampal Insulin Resistance Impairs Spatial Learning and Synaptic Plasticity
- (2015) Claudia A. Grillo et al. DIABETES
- Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline
- (2015) V. A. Gault et al. DIABETES OBESITY & METABOLISM
- Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats
- (2015) Volkan Solmaz et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Insulin receptor A and Sirtuin 1 synergistically improve learning and spatial memory following chronic salidroside treatment during hypoxia
- (2015) Kalpana Barhwal et al. JOURNAL OF NEUROCHEMISTRY
- Hippocampal insulin resistance and cognitive dysfunction
- (2015) Geert Jan Biessels et al. NATURE REVIEWS NEUROSCIENCE
- Insulin resistance-induced hyperglycemia decreased the activation of Akt/CREB in hippocampus neurons: Molecular evidence for mechanism of diabetes-induced cognitive dysfunction
- (2015) Qiong Xiang et al. NEUROPEPTIDES
- The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice
- (2015) Angélica Maria Sabogal-Guáqueta et al. NEUROPHARMACOLOGY
- Insulin resistance in brain alters dopamine turnover and causes behavioral disorders
- (2015) Andre Kleinridders et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The kynurenine pathway and neurodegenerative disease
- (2015) Daniel C. Maddison et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia
- (2015) Akihiro Shiina et al. Clinical Psychopharmacology and Neuroscience
- Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
- (2015) Jinan Chen et al. PLoS One
- Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood
- (2015) Yumi Shirai et al. PLoS One
- Impairment of hippocampal-dependent memory induced by juvenile high-fat diet intake is associated with enhanced hippocampal inflammation in rats
- (2014) Chloé Boitard et al. BRAIN BEHAVIOR AND IMMUNITY
- Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus
- (2014) Min Guo et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Insulin Action in Brain Regulates Systemic Metabolism and Brain Function
- (2014) A. Kleinridders et al. DIABETES
- Peroxisome Proliferator-Activated Receptor-Gamma Agonists for Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
- (2014) Jia Liu et al. DRUGS & AGING
- Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice
- (2014) Yanxing Chen et al. EXPERIMENTAL NEUROLOGY
- Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
- (2014) Yang Yu et al. JOURNAL OF NEURAL TRANSMISSION
- Cognitive Enhancing Treatment with a PPARγ Agonist Normalizes Dentate Granule Cell Presynaptic Function in Tg2576 APP Mice
- (2014) Miroslav N. Nenov et al. JOURNAL OF NEUROSCIENCE
- Effects of Long-Term Treatment with Quercetin on Cognition and Mitochondrial Function in a Mouse Model of Alzheimer’s Disease
- (2014) Dong-Mei Wang et al. NEUROCHEMICAL RESEARCH
- Association of the PPAR-γ Gene with Altered Glucose Levels and Psychosis Profile in Schizophrenia Patients Exposed to Antipsychotics
- (2014) Yun-Ru Liu et al. Psychiatry Investigation
- Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
- (2014) Michael Nauck Drug Design Development and Therapy
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2013) Jessica Freiherr et al. CNS DRUGS
- No Effect of Adjunctive, Repeated-Dose Intranasal Insulin Treatment on Psychopathology and Cognition in Patients With Schizophrenia
- (2013) Xiaoduo Fan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
- (2013) Jayasankar Kosaraju et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
- (2013) Jayasankar Kosaraju et al. NEUROPHARMACOLOGY
- No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia
- (2013) Jie Li et al. SCHIZOPHRENIA RESEARCH
- Chronic sulforaphane oral treatment accentuates blood glucose impairment and may affect GLUT3 expression in the cerebral cortex and hypothalamus of rats fed with a highly palatable diet
- (2013) C. G. Souza et al. Food & Function
- A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder
- (2012) Roger S McIntyre et al. BIPOLAR DISORDERS
- Impaired Insulin Sensitivity as Indexed by the HOMA Score Is Associated With Deficits in Verbal Fluency and Temporal Lobe Gray Matter Volume in the Elderly
- (2012) C. Benedict et al. DIABETES CARE
- DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption
- (2012) Noppamas Pipatpiboon et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cognitive Enhancement with Rosiglitazone Links the Hippocampal PPAR and ERK MAPK Signaling Pathways
- (2012) L. A. Denner et al. JOURNAL OF NEUROSCIENCE
- Intranasal delivery of insulin via the olfactory nerve pathway
- (2012) Dan B. Renner et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Epidermal Growth Factor Receptor Transactivation Is Necessary for Glucagon-Like Peptide-1 to Protect PC12 Cells from Apoptosis
- (2012) Ryosuke Kimura et al. NEUROENDOCRINOLOGY
- Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects
- (2012) Matthew R. Hayes PHYSIOLOGY & BEHAVIOR
- Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: A pilot study
- (2012) Zhenghui Yi et al. PSYCHIATRY RESEARCH
- Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration
- (2012) Yumi Shirai et al. Clinical Psychopharmacology and Neuroscience
- Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4
- (2011) Song Chen et al. AGE
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- IRS-2 Deficiency Impairs NMDA Receptor-Dependent Long-term Potentiation
- (2011) Eduardo D. Martín et al. CEREBRAL CORTEX
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Cognitive-Enhancing Effect of Quercetin in a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
- (2011) Napatr Sriraksa et al. Evidence-based Complementary and Alternative Medicine
- No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With Schizophrenia
- (2011) Xiaoduo Fan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Targeting the kynurenine pathway as a potential strategy to prevent and treat Alzheimer’s disease
- (2011) Chun-Yu Gong et al. MEDICAL HYPOTHESES
- Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents
- (2011) Brian C. Shonesy et al. NEUROBIOLOGY OF AGING
- Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
- (2011) Amit Gupta et al. NEUROPHARMACOLOGY
- Diagnosis and Treatment of Neuropsychiatric Disorders
- (2010) Katherine H. Taber et al. Annual Review of Medicine
- Prevalence of neuropsychiatric syndromes in Alzheimer's disease (AD)
- (2010) Jong Chul Youn et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
- (2010) Hayley B. Clay et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?
- (2010) Borja García-Bueno et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- SGLT2 inhibition — a novel strategy for diabetes treatment
- (2010) Edward C. Chao et al. NATURE REVIEWS DRUG DISCOVERY
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- Effect of second-generation antipsychotics on cognition: current issues and future challenges
- (2009) S Kristian Hill et al. Expert Review of Neurotherapeutics
- Nrf2:INrf2 (Keap1) signaling in oxidative stress
- (2009) James W. Kaspar et al. FREE RADICAL BIOLOGY AND MEDICINE
- PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
- (2009) Haruo Hanyu et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
- (2009) Tomohiko Sato et al. NEUROBIOLOGY OF AGING
- Is schizophrenia a neurodegenerative disorder?
- (2009) Bjørn Rishovd Rund NORDIC JOURNAL OF PSYCHIATRY
- Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons
- (2009) Y. Yao et al. PHYTOTHERAPY RESEARCH
- Metformin Addition Attenuates Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: A Double-Blind, Placebo-Controlled Study
- (2008) Ren-Rong Wu et al. AMERICAN JOURNAL OF PSYCHIATRY
- Inflammation and the glutamate system in schizophrenia: implications for therapeutic targets and drug development
- (2008) Norbert Müller EXPERT OPINION ON THERAPEUTIC TARGETS
- Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain
- (2008) Ren-Rong Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration
- (2008) Caroline André et al. JOURNAL OF NEUROIMMUNOLOGY
- Suppression of NF-κβ signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits
- (2008) Anurag Kuhad et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More